Detalhe da pesquisa
1.
Trifluridine/Tipiracil and Regorafenib in Patients with Metastatic Colorectal Cancer: A Retrospective Study at a Tertiary Oncology Center.
Oncologist
; 26(12): e2161-e2169, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406678
2.
Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib.
Oncologist
; 25(1): e75-e84, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591140
3.
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.
J Immunother Cancer
; 12(1)2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272561
4.
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI Cancer.
JCO Precis Oncol
; 7: e2200572, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343200
5.
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344102
6.
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.
Clin Cancer Res
; 29(24): 5047-5056, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819936
7.
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
JCO Precis Oncol
; 7: e2200342, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634297
8.
Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use.
J Med Econ
; 25(1): 817-825, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35593483
9.
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.
J Clin Invest
; 131(24)2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907910
10.
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival.
J Immunother Cancer
; 9(9)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593617
11.
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma.
Cancer Discov
; 11(10): 2488-2505, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926920
12.
Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib.
Clin Colorectal Cancer
; 17(3): e531-e539, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29803544
13.
Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine.
Cancer Discov
; 8(9): 1096-1111, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903880